cnbc_topnews

Big Tech earnings show how big, smart spending can be rewarded by the market

big tech earnings this quarter sent a clear signal: heavy spending on ai infrastructure is being rewarded, not punished. alphabet, amazon, apple, microsoft, and meta — five of the magnificent seven — all reported massive capital expenditure plans for data centers, and the market reacted differently to each.

alphabet guided $180-190 billion in data center spend and saw its stock rise 12% for the week, from $349 to $385. google cloud grew 63% to $20 billion in quarterly revenue, with an $80 billion annual run rate. amazon guided $200 billion in spend, with aws growing 28% to $37.6 billion — its fastest growth in 15 quarters — and the stock gained 1.6%. apple spent just $13 billion, has a 2.5 billion device installed base, and got google's gemini at effectively no cost; its stock rose 3.4% to $280.

microsoft guided $190 billion in spend, but azure's 40% growth included openai compute demand the street couldn't parse. the stock fell 2.4% for the week. meta guided $125-145 billion, then added another $10 billion, with no cloud business to monetize it. the stock dropped 9.8%. the takeaway from the quarter: spend big and spend well, or get left behind.

source: cnbc_topnews
sentiment: +0.60 · impact: 0.70

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

source: marketwatch_top sentiment: -0.70 · impact: 0.80

Warsh's take on Fed independence is met with confusion and some concern

kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out

Read more

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

Warsh's take on Fed independence is met with confusion and some concern

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds